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Abstract
Background: Informal caregivers provide extended support to people with cancer but they receive little support
from the health care system to assist them in their caring role. The aim of this single-blind, multi-centre, randomised
controlled trial was to test the efficacy of a telephone outcall program to reduce caregiver burden and unmet needs,
and improve psychological well-being among cancer caregivers, as well as evaluating the potential impact on patient
outcomes.
Methods: Cancer patient/caregiver dyads (N = 216) were randomised to a telephone outcall program (n = 108) or
attention control group (n = 108). The primary outcome was self-reported caregiver burden. Secondary endpoints
included depressive symptoms, unmet needs, self-esteem, self-empowerment, and health literacy. Data were
collected at baseline and at both 1 and 6 months post-intervention. An intention to treat analysis was performed.
Results: The intervention had no effect on the primary outcome (caregiver burden), but reduced the number of
caregiver unmet needs (intervention group baseline, mean = 2.66, 95% confidence interval (CI) [1.91–3.54]; intervention
group 1 month post intervention, mean = 0.85, 95%CI [0.42–1.44]; control group baseline, mean = 1.30 95%CI [0.80–1.94],
control group 1 month post intervention, mean = 1.02 95%CI [0.52–1.69]; p = 0.023). For caregivers at risk for depression,
the intervention had a significant effect on caregivers’ confidence in having sufficient information to manage their health
(p = 0.040). No effects were found for patients’ depressive symptoms, unmet needs, self-empowerment, and other health
literacy domains.
Conclusions: While caregiver burden was not reduced, the outcall program was effective in reducing unmet needs in
caregivers. Provision of cancer information and support via a telephone service may represent a feasible approach
to reducing unmet needs among cancer caregiver populations.
Trial registration: ACTRN12613000731796; prospectively registered on 02/07/2013.
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Background
With the rise of cancer globally [1], the number of informal
caregivers who provide uncompensated care to cancer pa-
tients is increasing proportionally [2]. In addition to their
existing obligations, caregivers are often confronted with
role transitions and new responsibilities of managing the
needs of the person diagnosed with cancer [3, 4]. There is
increasing recognition that informal caregivers of people
with cancer need information and support from the health
care system [5, 6]. Failure to address these needs can im-
pact substantially on caregivers’ health causing consider-
able burden, anxiety, and depression [5, 7–10].
Since the Australian Clinical Practice Guidelines for
Psychosocial Care of Adults with Cancer were intro-
duced [11], no recommendations have been made for
systematically supporting cancer caregivers. Although
psychosocial interventions have been developed to sup-
port caregivers (e.g. [12–14]), a meta-analysis of 29 ran-
domised controlled trials comprising psychoeducation,
skills training, or therapeutic counselling interventions
found only small to moderate effects but significantly
reduced caregiver burden and improved aspects of qual-
ity of life [15]. Since then there have been calls for other
tailored interventions to be designed and tested, particu-
larly for those caring for patients in the early stages of
the cancer trajectory [16, 17].
To address the gap in the literature, we linked a high
quality and credible telephone-based information and
support service (13 11 20) with caregivers who were car-
ing for people recently diagnosed with cancer, in the
early stages of treatment. Cancer Council’s 13 11 20
Information and Support is a free telephone service pro-
viding tailored support to people affected by cancer
across Australia. At present, individuals need to initiate
contact with the 13 11 20 service. The aim of this study
was to evaluate whether a new model of service delivery
(i.e. a telephone outcall program), provided by the estab-
lished 13 11 20 service, reduced caregiver burden and
unmet needs, and improved psychological health among
caregivers of people newly diagnosed with cancer.
Methods
Research design
This study was a single blind, multi-centre, randomised
controlled trial. A detailed description of the study
methods is available in the published protocol [18].
Briefly, patient/caregiver dyads were recruited at one pri-
vate and three public health services in Melbourne and
Adelaide, Australia, between August 2013 and December
2014. Eligible dyads were approached by trained research
personnel at oncology outpatient units during treatment
cycles 2–5 of adjuvant chemotherapy and/or fractions
2–10 of radiotherapy. A brief introduction to the trial
was provided and interested dyads were given an
information package to take home and followed up to
confirm participation. Consenting dyads completed sur-
veys at baseline and at 1 and 6 months post-
intervention.
Participants
Eligible patients were identified by nurses through hos-
pital patient management systems and included those
with a primary cancer diagnosis (any cancer type, stages
I-III) who received treatment with curative intent. Mini-
mum age of both patients and caregivers was 18 years
and dyads had to be able to read and understand English
language and present with no cognitive impairment to
participate in the study. Caregivers were nominated by
the patient as the person most involved in providing
support throughout the illness trajectory.
Cancer council 13 11 20 information and support service
Cancer Council Australia are the largest non-government
provider of cancer support services (http://www.cancer.or-
g.au/). Their signature service is the 13 11 20 telephone
information and support service, run by specialist oncol-
ogy nurses with extensive clinical and counselling experi-
ence, which they use to educate, support and link callers
to other internal and external services, depending on their
needs.
Randomisation and group allocation
A computer-generated randomisation table stratified by
health service was produced by the trial statistician and
made accessible to the study co-ordinator who con-
ducted the randomization. Dyads were randomised to
the intervention or the attention control group and par-
ticipants were blinded after group allocation. In the
intervention group, caregivers received three calls from
a 13 11 20 nurse with the first outcall at the start of the
program (5–10 days post-randomisation), the second
outcall 1 month later and the last outcall 3 months fol-
lowing the second call. During each outcall, the nurse
measured caregivers’ distress using the Distress Therm-
ometer [19] and offered referral to appropriate services
to those with elevated scores (distress ≥4 and impact
≥3). The nurse then raised six topics for further discus-
sion to address caregivers’ potential unmet needs: psy-
chological distress, health literacy, physical health, family
support, financial burden, and practical difficulties (e.g.
legal affairs). Caregivers could raise additional topics if
required. In the attention control group, caregivers re-
ceived three outcalls at the same time points as those in
the intervention group (mean call duration: 3 min,
22 min; respectively). These outcalls were conducted by
trained research personnel who supplied caregivers with
the 13 11 20 number to self-initiate contact if needed,
no other information or support was provided.
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Measures
Demographic characteristics were collected at baseline
and included information on the caregiver (age, gen-
der, postcode, type of relationship to the patient, liv-
ing situation, household size, level of education) and
patient (age, gender, postcode, treatment type, cancer
diagnosis). Details of the measures used for caregiver
and patient outcomes have been published [18].
Briefly, the primary outcome (caregiver burden) was
measured using the Zarit Burden Interview (ZBI),
which consists of 22 items [20]. A total score is cal-
culated through summing individual item scores
(range from 0 to 88) with higher scores indicating
greater burden. Scores of 24 and above have been
found to be indicative of risk for depression [21]. Sec-
ondary outcome measures for caregivers and patients
were the Centre of Epidemiologic Studies – Depres-
sion scale (CES-D) [22] to measure depressive symp-
toms in caregivers and patients. This instrument
consists of 20 items, each rated on a 4-point scale
ranging from ‘rarely or none of the time’ to ‘most or
all of the time’. The Supportive Care Needs Survey
for Partners & Caregivers (SCNS-P&C, 45 items) [23],
and the Supportive Care Needs Survey (SCNS-SF34,
34 items) [24] were used to assess the perceived
needs of caregivers and cancer patients respectively.
Items on both tools are rated on a 5-point scale ran-
ging from ‘not applicable’ to ‘high need’. The Health
Literacy Questionnaire (HLQ) [25] was used to assess
caregivers’ and patients’ ability to obtain, understand
and use health information. The HLQ consists of 44
items, each rated on a 5-point scale ranging from
‘cannot do’ to ‘very easy’. The health education im-
pact Questionnaire (heiQ) [26] was used to measure
self-empowerment. The heiQ contains 40 items, each
rated on a 4-point scale ranging from ‘strongly dis-
agree’ to ‘strongly agree’. The self-esteem subscale of
the Caregiver Reaction Assessment (CRA, 7 items)
was used to measure positive aspects of caregiving on
a 5-point scale ranging from ‘strongly disagree’ to
‘strongly agree’ [27]. A self-designed utility assessment
was included in the 1 month post-intervention survey
to evaluate caregivers’ perceptions of the outcall pro-
gram (i.e. ‘I feel it was worth my time and effort to
take part in the outcall program’).
Sample size calculation
The primary outcome was change in caregiver burden
as measured by the ZBI. A sample size of 180 dyads
(90 per group) at the end of the trial period was esti-
mated to detect a moderate effect size (d = 0.5), which
corresponds to a difference between the treatment
groups of 6.3 units on the ZBI Total score, with 90%
power and alpha = 0.05 (two-sided).
Data analysis
An intention to treat analysis was performed and ana-
lyses were undertaken using GenStat and Stata. A mixed
model analysis, using the restricted maximum likelihood
method (REML), was used to calculate the between and
within caregiver components of variance and the pre-
dicted main-effect means for study group, time (baseline
and one-month post intervention) and the two-way
interaction predicted means. A difference between the
research groups in the change in caregiver burden was
claimed if the F-test for the two-way interaction was sig-
nificant (P < 0.05). Mixed model analyses were also used
to analyse all secondary caregiver endpoints (CRA, CES-
D, heiQ domains, HLQ subscales). Data from the 45-
item SCNS-P&C were summarised as the total number
of (moderate/high) unmet needs [7, 23] and a variance-
stabilising square-root transformation was applied in
mixed model analyses of this endpoint.
Results
Caregiver and patient sample
Overall, 839 patient/caregiver dyads were approached for
study participation, of which 737 were eligible to partici-
pate and 216 (29%) provided informed consent and were
included in each analysis. Dyads were randomized into
intervention (n = 108) and attention control (n = 108)
groups (Fig. 1).
The overall attrition rate at 1-month post interven-
tion was 30% (intervention, 27%; control, 32%). Partici-
pants’ demographic characteristics are provided in
Table 1. At baseline, there were no significant differ-
ences between groups in participants’ demographic or
clinical characteristics.
Caregiver outcomes
Analyses of outcome variables for caregivers are summa-
rized in Table 2.
Caregiver burden
At baseline, the primary outcome variable caregiver bur-
den (ZBI Total Score), in both the intervention group
(M = 18.99, SE = 1.17) and the control group (M = 18.05,
SE = 1.17) was low. The intervention had no significant
effect on caregiver burden (P = 0.921). The estimated
between-individual and within-individual variance com-
ponents were 97.2 and 50.4 respectively (ICC = 0.659).
Caregiver unmet needs
Unmet needs declined in both groups over the course
of the intervention period (P < 0.001) and there was a
significant interaction between study group and time
(P = 0.023) with a greater decline from baseline to
month 1 in the intervention group compared to the
control group (t = −2.703; df = 312.3; P = 0.007). The
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decline from baseline to month 6 appeared to be
greater in the intervention group but this was not
significant at the conventional 5% level (t = −1.661; df
= 312.3; P = 0.098). Back-transformed means (95%
confidence intervals) at baseline, month 1 and month
6 were 1.30 (0.80, 1.94), 1.02 (0.52, 1.69) and 0.17
(0.01, 0.51) respectively in the control group, and
2.66 (1.91, 3.54), 0.85 (0.42, 1.44) and 0.28 (0.06,
0.68) respectively in the intervention group.
Caregiver self-empowerment (heiQ) and health literacy
There were no statistically significant differences between
the study groups in their changes over time in heiQ sub-
scales as indicated by the outcomes of F-tests for time by
treatment interactions (Table 2). No significant effects
were found for health literacy subscales (data not shown).
Caregiver self-esteem
Caregiver self-esteem (CRA) declined in both groups
from baseline to months 1 and 6 (P = 0.045) and there
was no significant difference between the groups in their
declines over time (P = 0.320).
Depressive symptoms and caregivers at risk for depression
No significant effects were found for depressive symp-
toms (CES-D Total Score). A subsample of caregivers
had burden scores of 24 or greater (intervention, n = 37;
control, n = 31), which indicated risk for depression.
Caregivers in these groups did not differ with respect to
baseline demographic and clinical characteristics
(Table 3). Significant demographic differences were
found when comparing caregivers at risk for depression
(ZBI ≥ 24) with those not at risk (ZBI < 24). Caregivers at
Assessed for eligibility
(N=839)
Did not meet inclusion criteria (n=102)
Patient has no carer (n=81)
Patient does not speak English/has
significant cognitive impairment (n=17)
Carer does not speak English/ has 
significant cognitive impairment (n=4)
Declined to participate (n=521)
No time/too busy (n=147)
Not interested in research (n=163)
No need for support (n=113)
Carer/patient too sick, too burdensome 
(n=74)
Could not be contacted for 48hr call (n=24)
Time 2
Withdrew from study (n=6)
Patient passed away (n=2)
Dyad was no longer interested in participating (n=3)
Patient became very unwell (n=1)
Lost to follow-up
Did not complete questionnaire 2 (carer: n=22)
Did not complete questionnaire 2 (patient: n=23)
Time 3
Withdrew from study (n=1)
Patient passed away (n=1)
Lost to follow-up




Withdrew from study (n=4)
Patient passed away (n=3)
Dyad was no longer interested in participating (n=1)
Lost to follow-up 
Did not complete questionnaire 2 (carer: n=31)
Did not complete questionnaire 2 (patient: n=31)
Time 3
Withdrew from study (n=3)
Patient passed away (n=1)
Dyad was no longer interested in participating (n=1) 
No reason given (n=1)
Lost to follow-up







Fig. 1 Consort diagram showing recruitment of patient/caregiver dyads into the PROTECT study
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risk were about 6 years younger (52.9 vs 58.4 years;
P = 0.003) and had more people in their households
(2.9 vs 2.5 mean household size; P = 0.04) than those
not at risk (Table 4). For caregivers at risk, the inter-
vention had a significant effect on having sufficient
information to manage caregivers health (P = 0.040).
Post hoc analyses showed an increase in caregivers’
confidence that they had sufficient information to
manage their health (HLQ Scale 2) between baseline
and 6 months (P = 0.002) and between 1 month and
6 months (P = 0.009) in the intervention group but no
such changes were observed in the control group
(P > 0.30). No significant differences between the
groups, in their changes over time, were observed for
the other caregiver outcome variables.
For patients associated with caregivers at risk of depres-
sion, there was a significant decline in emotional distress
from baseline (BL) to 1 month (M1) (P = 0.001). Investiga-
tion of the significant three-way interaction (P = .027)
indicated a significant decrease in emotional distress in
the control group (BL mean = 2.592, M1 mean = 2.046,
SED = 0.133, P < .001) but a non-significant decrease in
the intervention group (BL mean = 2.487, M1 mean =
2.288, SED = 0.117, P = .089). No other statistically signifi-
cant effects were found.
Patient outcomes
No significant differences between the groups, in their
changes over time were observed for patients’ depressive
symptoms, unmet needs or health literacy (Additional file 1:
Table s1).
A significant improvement in positive and active en-
gagement in life (heiQ, domain 2) among patients in the
control group, but not the intervention group, was noted
(t = 2.972; df = 168.4; P = 0.003). No significant effects
were found for other subscales of the heiQ.
Self-initiated contact to the 13 11 20 service by caregivers
in the attention control group
Of the 108 participants in the attention control group,
seven caregivers (6%) initiated contact to the 13 11 20 ser-
vice between outcalls. Of those, two were repeat callers
living in outer regional areas.
Perceptions of caregivers on the outcall program
Caregivers in the intervention group were asked in what
way the outcall program had helped them in their role
as a caregiver (Fig. 2). Most caregivers reported that the
service had helped them to reduce their worries (74%),
to think positively about their situation (78%), and to
think things through (82%).
Table 1 Baseline demographic and clinical characteristics of
patients and caregivers in the PROTECT trial by study group
(N = 216)
Characteristics Control Intervention P
Patient demographics
Age, mean (SD), years 59.8
(12.4)
58.8 (12.1) .58
Gender, n (%) .58
Male 49 (45.4) 45 (41.7)
Female 59 (54.6) 63 (58.3)
Clinical data
Type of Cancer, n (%) .21
Solid 92 (85.2) 98 (90.7)
Haematological 16 (14.8) 10 (9.3)
Treatment regimen, n (%) .85
Chemotherapy 40 (37.0) 42 (38.9)
Radiotherapy 38 (35.2) 34 (31.5)
Chemo/Radio combined 30 (27.8) 32 (29.6)
Caregiver demographics
Age, mean (SD), years 56.3
(14.2)
57.2 (11.6) .59
Gender, n (%) .27
Male 42 (38.9) 50 (46.3)








Country of birth, n (%) .46
Australia 84 (80.8) 83 (84.7)
Other 20 (19.2) 15 (15.3)
Lives with patient, n (%) .85
Yes 90 (83.3) 91 (84.3)
No 18 (16.7) 17 (15.7)
Relationship to patient, n (%) .87
Spouse/partner 85 (78.7) 86 (79.6)
Other (e.g. parent, adult child, friend) 23 (21.3) 22 (20.4)
Household size, mean (SD)
Number of people ≥18 years 2.2 (0.7) 2.2 (0.7) .85
Number of people <18 years 0.4 (0.9) 0.4 (0.9) .88
Total household size 2.6 (1.1) 2.6 (1.2) .81
Education status, n (%) .85
Primary/secondary school 48 (44.9) 47 (43.5)
Certificate/Diploma 27 (25.2) 25 (23.1)
University Degree 32 (29.9) 36 (33.3)
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Table 2 -Time (BL = Baseline, M1 = Month 1, M6 = Month 6) by treatment means for outcome variables for caregiver
Outcome Control Intervention Δ = Intervention - Control
Mean SEa n (or P-value)b Mean SE n (or P-value) Δ SEDc P_value
ZBIe
BL 18.05 1.17 108 18.99 1.17 107 0.95 1.65 0.568
M1 17.81 1.31 73 19.39 1.27 82 1.58 1.82 0.386
M6 17.20 1.33 69 18.46 1.31 73 1.26 1.87 0.500
M1-BL −0.24 1.13 0.835 0.40 1.09 0.713
M6-BL −0.85 1.16 0.464 −0.53 1.14 0.639
M6-M1 −0.61 1.23 0.620 −0.93 1.16 0.422 0.921d
CRAf Total
BL 30.07 0.44 108 30.80 0.44 105 0.73 0.62 0.243
M1 29.80 0.50 73 29.58 0.49 80 −0.22 0.70 0.750
M6 29.76 0.52 66 29.66 0.51 70 −0.09 0.73 0.897
M1-BL −0.27 0.49 0.578 −1.22 0.48 0.012
M6-BL −0.31 0.51 0.538 −1.13 0.50 0.025
M6-M1 −0.04 0.54 0.940 0.09 0.52 0.867 0.320
SCNS-P&Cg (√ transformed)
BL 1.14 0.13 108 1.63 0.13 108 0.49 0.18 0.007
M1 1.01 0.15 75 0.92 0.14 83 −0.09 0.20 0.659
M6 0.41 0.15 68 0.53 0.15 73 0.12 0.21 0.577
M1-BL −0.13 0.15 0.401 −0.71 0.15 <0.001
M6-BL −0.73 0.16 <0.001 −1.10 0.16 <0.001
M6-M1 −0.60 0.17 0.001 −0.39 0.16 <0.001 0.023
CES-Dh Total
BL 11.46 0.91 107 13.24 0.91 108 1.79 1.29 0.168
M1 10.98 1.02 75 12.32 0.99 82 1.34 1.42 0.347
M6 10.62 1.04 68 12.04 1.02 73 1.42 1.46 0.334
M1-BL −0.48 0.89 0.592 −0.93 0.85 0.280
M6-BL −0.83 0.92 0.369 −1.20 0.89 0.180
M6-M1 −0.36 0.97 0.715 −0.27 0.92 0.765 0.926
heiQi Dom1 HDB
BL 2.90 0.07 107 2.83 0.07 108 −0.06 0.10 0.548
M1 3.05 0.08 75 2.81 0.08 82 −0.24 0.11 0.034
M6 2.96 0.08 68 2.92 0.08 73 −0.04 0.12 0.749
M1-BL 0.15 0.07 0.026 −0.03 0.07 0.680
M6-BL 0.06 0.07 0.379 0.09 0.07 0.202
M6-M1 −0.09 0.07 0.224 0.11 0.07 0.105 0.080
heiQ Dom2 PAEL
BL 3.15 0.05 108 3.05 0.05 108 −0.10 0.07 0.157
M1 3.18 0.06 75 3.02 0.05 82 −0.17 0.08 0.035
M6 3.22 0.06 68 3.06 0.06 73 −0.16 0.08 0.053
M1-BL 0.03 0.05 0.464 −0.03 0.05 0.509
M6-BL 0.07 0.05 0.166 0.01 0.05 0.782
M6-M1 0.03 0.05 0.518 0.04 0.05 0.377 0.564
heiQ Dom3 ED
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Table 2 -Time (BL = Baseline, M1 = Month 1, M6 = Month 6) by treatment means for outcome variables for caregiver (Continued)
Outcome Control Intervention Δ = Intervention - Control
Mean SEa n (or P-value)b Mean SE n (or P-value) Δ SEDc P_value
BL 1.70 0.06 106 1.78 0.06 106 0.09 0.08 0.303
M1 1.73 0.07 75 1.95 0.06 82 0.22 0.09 0.015
M6 1.68 0.07 67 1.91 0.07 73 0.23 0.10 0.016
M1-BL 0.03 0.06 0.653 0.17 0.06 0.005
M6-BL −0.02 0.06 0.766 0.13 0.06 0.036
M6-M1 −0.05 0.07 0.488 −0.04 0.06 0.537 0.144
heiQ Dom4 SMI
BL 3.17 0.04 106 3.16 0.04 108 −0.01 0.06 0.859
M1 3.13 0.05 75 3.07 0.04 82 −0.06 0.06 0.354
M6 3.22 0.05 68 3.14 0.05 73 −0.08 0.07 0.209
M1-BL −0.04 0.04 0.418 −0.08 0.04 0.047
M6-BL 0.06 0.05 0.199 −0.01 0.04 0.749
M6-M1 0.09 0.05 0.051 0.07 0.05 0.124 0.489
heiQ Dom5 CAA
BL 3.38 0.05 105 3.31 0.05 104 −0.07 0.06 0.268
M1 3.30 0.05 75 3.20 0.05 82 −0.11 0.07 0.124
M6 3.38 0.05 67 3.25 0.05 72 −0.13 0.07 0.083
M1-BL −0.08 0.05 0.117 −0.12 0.05 0.016
M6-BL 0.00 0.05 0.980 −0.06 0.05 0.256
M6-M1 0.08 0.05 0.145 0.06 0.05 0.248 0.701
heiQ Dom6 STA
BL 3.17 0.04 102 3.15 0.04 103 −0.02 0.06 0.794
M1 3.04 0.05 74 3.01 0.05 83 −0.04 0.07 0.560
M6 3.17 0.05 66 3.09 0.05 73 −0.08 0.07 0.262
M1-BL −0.12 0.05 0.015 −0.15 0.05 0.002
M6-BL 0.00 0.05 0.997 −0.06 0.05 0.202
M6-M1 0.12 0.05 0.026 0.08 0.05 0.108 0.672
heiQ Dom7 SIS
BL 3.23 0.05 106 3.12 0.05 104 −0.11 0.07 0.114
M1 3.08 0.05 75 2.98 0.05 83 −0.10 0.08 0.212
M6 3.24 0.06 68 3.05 0.06 73 −0.19 0.08 0.016
M1-BL −0.15 0.05 0.003 −0.13 0.05 0.006
M6-BL 0.01 0.05 0.778 −0.07 0.05 0.191
M6-M1 0.16 0.05 0.003 0.07 0.05 0.193 0.392
heiQ Dom8 HSN
BL 3.27 0.05 105 3.17 0.05 103 −0.10 0.07 0.153
M1 3.23 0.05 75 3.07 0.05 83 −0.16 0.08 0.034
M6 3.39 0.06 67 3.15 0.05 73 −0.24 0.08 0.003
M1-BL −0.04 0.05 0.409 −0.10 0.05 0.032
M6-BL 0.12 0.05 0.015 −0.02 0.05 0.753
M6-M1 0.16 0.05 0.002 0.09 0.05 0.086 0.144
HLQj S1
BL 3.24 0.05 105 3.11 0.05 103 −0.13 0.07 0.083
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Table 2 -Time (BL = Baseline, M1 = Month 1, M6 = Month 6) by treatment means for outcome variables for caregiver (Continued)
Outcome Control Intervention Δ = Intervention - Control
Mean SEa n (or P-value)b Mean SE n (or P-value) Δ SEDc P_value
M1 3.25 0.06 73 3.15 0.06 83 −0.10 0.08 0.208
M6 3.30 0.06 67 3.17 0.06 73 −0.13 0.08 0.109
M1-BL 0.01 0.05 0.913 0.03 0.05 0.492
M6-BL 0.06 0.05 0.220 0.06 0.05 0.239
M6-M1 0.06 0.05 0.288 0.03 0.05 0.604 0.892
HLQ S2
BL 3.15 0.04 106 3.10 0.04 105 −0.05 0.06 0.388
M1 3.15 0.05 74 3.09 0.05 83 −0.06 0.07 0.392
M6 3.23 0.05 67 3.19 0.05 73 −0.04 0.07 0.552
M1-BL −0.01 0.05 0.880 −0.01 0.04 0.785
M6-BL 0.08 0.05 0.107 0.09 0.05 0.058
M6-M1 0.08 0.05 0.097 0.10 0.05 0.034 0.970
HLQ S3
BL 2.96 0.05 107 2.89 0.05 105 −0.07 0.07 0.282
M1 2.95 0.05 74 2.91 0.05 83 −0.04 0.07 0.616
M6 2.99 0.05 67 2.91 0.05 72 −0.08 0.08 0.286
M1-BL −0.02 0.05 0.758 0.02 0.05 0.692
M6-BL 0.03 0.05 0.558 0.02 0.05 0.695
M6-M1 0.05 0.05 0.405 0.00 0.05 0.987 0.815
HLQ S4
BL 3.19 0.05 106 3.04 0.05 105 −0.16 0.07 0.019
M1 3.12 0.05 74 3.02 0.05 83 −0.10 0.07 0.166
M6 3.23 0.05 68 3.04 0.05 73 −0.19 0.07 0.010
M1-BL −0.07 0.05 0.119 −0.02 0.04 0.721
M6-BL 0.04 0.05 0.382 0.00 0.05 0.940
M6-M1 0.11 0.05 0.024 0.02 0.05 0.682 0.381
HLQ S5
BL 2.90 0.05 104 2.86 0.05 104 −0.04 0.07 0.587
M1 2.89 0.06 73 2.88 0.05 83 −0.01 0.08 0.878
M6 2.95 0.06 67 2.91 0.06 73 −0.04 0.08 0.587
M1-BL −0.01 0.05 0.802 0.01 0.05 0.788
M6-BL 0.05 0.05 0.372 0.04 0.05 0.412
M6-M1 0.06 0.06 0.282 0.03 0.05 0.578 0.903
HLQ S6
BL 4.22 0.06 106 4.23 0.06 104 0.01 0.09 0.863
M1 4.19 0.07 74 4.28 0.07 83 0.10 0.10 0.322
M6 4.28 0.07 68 4.18 0.07 73 −0.10 0.10 0.331
M1-BL −0.03 0.07 0.626 0.05 0.07 0.470
M6-BL 0.06 0.07 0.388 −0.05 0.07 0.454
M6-M1 0.09 0.07 0.207 −0.10 0.07 0.158 0.168
HLQ S7
BL 4.14 0.06 104 4.12 0.06 104 −0.03 0.09 0.772
M1 4.10 0.07 73 4.21 0.07 83 0.11 0.10 0.259
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Discussion
This study tested the impact of a telephone outcall inter-
vention delivered by two Australian Cancer Council 13 11
20 services on the psychological distress of caregivers of
newly diagnosed cancer patients. Results indicated that the
outcall program did not reduce caregivers’ overall caregiver
burden. This may be due to the inclusion of caregivers with
various levels of burden in this study and the fact that bur-
den levels at baseline, for the majority of caregivers, were
reasonably low, limiting the detection of changes over time.
While the outcall program had no significant impact
on depressive symptoms in caregivers, it was associated
with an increase in health literacy in a subgroup of care-
givers who were at increased risk for depression at base-
line (ZBI scores of ≥24). For these caregivers, the
intervention significantly increased caregivers’ confi-
dence in having sufficient information to manage their
own (as opposed to the patient’s) health. It is possible
that these caregivers had low health literacy, hence the
high burden levels, and the informational component of
the intervention was able to meet caregivers’ needs in
this domain. We also found that caregivers ‘at risk’ were
those who were younger in age and had more people
residing in their households than those not at risk. Since
this subgroup was relatively small (intervention, n = 37;
control, n = 31) our ability to detect a significant impact,
if in fact it exists, of the outcall program was impaired.
Future research may consider screening caregivers for
age, household size, and associated burden such as the
care of young children or employment, as those may
benefit from interventions of this type.
The outcall program produced positive changes over
time with a greater reduction in the number of care-
givers’ reported unmet needs. The six topics raised for
discussion by the 13 11 20 nurses at each outcall were
specifically chosen to address caregiver’s supportive care
Table 2 -Time (BL = Baseline, M1 = Month 1, M6 = Month 6) by treatment means for outcome variables for caregiver (Continued)
Outcome Control Intervention Δ = Intervention - Control
Mean SEa n (or P-value)b Mean SE n (or P-value) Δ SEDc P_value
M6 4.19 0.07 68 4.14 0.07 73 −0.05 0.10 0.629
M1-BL −0.04 0.06 0.498 0.09 0.06 0.143
M6-BL 0.05 0.07 0.488 0.02 0.06 0.717
M6-M1 0.09 0.07 0.200 −0.07 0.06 0.306 0.192
HLQ S8
BL 4.15 0.06 105 4.13 0.06 104 −0.03 0.09 0.774
M1 4.08 0.07 73 4.18 0.07 83 0.09 0.10 0.341
M6 4.19 0.07 68 4.13 0.07 73 −0.05 0.10 0.614
M1-BL −0.07 0.07 0.333 0.05 0.07 0.473
M6-BL 0.03 0.07 0.657 0.01 0.07 0.928
M6-M1 0.10 0.08 0.192 −0.04 0.07 0.559 0.336
HLQ S9
BL 4.31 0.05 104 4.30 0.05 104 −0.01 0.08 0.916
M1 4.27 0.06 74 4.37 0.06 83 0.10 0.08 0.234
M6 4.32 0.06 68 4.37 0.06 73 0.05 0.09 0.563
M1-BL −0.04 0.06 0.512 0.07 0.06 0.197
M6-BL 0.00 0.06 0.948 0.06 0.06 0.279
M6-M1 0.04 0.06 0.504 −0.01 0.06 0.884 0.390
a SE Standard Error of the Mean or a difference in Time Means
b Sample sizes (n) for means and p-values for time differences within treatment groups
c SED Standard Error of the Difference in Treatment group means within a Time
d P-value for the 2 degree-of-freedom test for a Time by Treatment group interaction
e ZBI Zarit Burden Interview
f CRA Caregiver Reaction Assessment
g SCNS – P&C Supportive Care Needs Survey – Partner & Caregivers
h CES-D Centre for Epidemiologic Studies – Depression
i heiQ health education impact Questionnaire: Domain 1 – health directed behaviour (HDB), Domain 2 – positive and active engagement in life (PAEL), Domain 3 –
emotional distress (ED), Domain 4 – self monitoring and insight (SMI), Domain 5 – constructive attitudes and approaches (CAA), Domain 6 – skills and technique
acquisition (STA), Domain 7 – social integration and support (SIS), Domain 8 – health service navigation (HSN)
j HLQ Health Literacy Questionnaire: S1 – feeling understood and supported by healthcare providers, S2 – having sufficient information to manage my health, S3 –
actively managing my health, S4 – social support for health, S5 – appraisal of health information, S6 – ability to actively engage with health care providers, S7 –
navigating the health care system, S8 – ability to find good health information, S9 – understanding health information well enough to know what to do
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Table 3 –Baseline demographic and clinical characteristics of
patients and caregivers in the PROTECT trial by study group:
Dyads including caregivers at risk of depression (n = 68)
Characteristics Control Intervention P
Patient demographics
Age, mean (SD), years 59.1
(12.9)
57.7 (11.6) .63
Gender, n (%) .81
Male 15 (48.4) 19 (51.4)
Female 16 (51.6) 18 (48.6)
Clinical data
Type of Cancer, n (%) .09
Solid 24 (77.4) 34 (91.9)
Haematological 7 (22.6) 3 (8.1)
Treatment regimen, n (%) .17
Chemotherapy 14 (45.2) 13 (35.1)
Radiotherapy 11 (35.5) 9 (24.3)
Chemo/Radio combined 6 (19.4) 15 (40.5)
Caregiver demographics
Age, mean (SD), years 53.6
(12.9)
52.3 (12.3) .67
Gender, n (%) .67
Male 11 (35.5) 15 (40.5)
Female 20 (64.5) 22 (59.5)
Indigeneity- Aboriginal/Torres Strait Islander,
n (%)
–




Country of birth, n (%) .21
Australia 23 (79.3) 29 (90.6)
Other 6 (20.7) 3 (9.4)
Lives with patient, n (%) .52
Yes 26 (83.9) 33 (89.2)
No 5 (16.1) 4 (10.8)
Relationship to patient, n (%) .33
Spouse/partner 23 (74.2) 31 (83.8)
Other (e.g. parent, adult child, friend) 8 (25.8) 6 (16.2)
Household size, mean (SD)
Number of people ≥18 years 2.3 (0.8) 2.2 (0.6) .65
Number of people <18 years 0.6 (1.0) 0.6 (1.2) .97
Total household size 2.9 (1.3) 2.8 (1.3) .84
Education status, n (%) .99
Primary/secondary school 11 (36.7) 13 (35.1)
Certificate/Diploma 10 (33.3) 13 (35.1)
University Degree 9 (30.0) 11 (39.7)
Table 4 Baseline demographic and clinical characteristics of
patients and caregivers in the PROTECT trial: Comparison of
dyads including caregivers at risk of depression with those not
at risk (n = 215a)
Characteristics Caregivers not at
risk (n = 147)
Caregivers at
risk (n = 68)
P
Patient demographics
Age, mean (SD), years 59.6 (12.3) 58.3 (12.1) .47
Gender, n (%) .18
Male 59 (40.1) 34 (50.0)
Female 88 (59.9) 34 (50.0)
Clinical data
Type of Cancer, n (%) .42
Solid 131 (89.1) 58 (85.3)
Haematological 16 (10.9) 10 (14.7)
Treatment regimen, n (%) .74
Chemotherapy 55 (37.4) 27 (39.7)
Radiotherapy 51 (34.7) 20 (29.4)
Chemo/Radio combined 41 (27.9) 21 (30.9)
Caregiver demographics
Age, mean (SD), years 58.4 (12.8) 52.9 (12.5) .003
Gender, n (%) .36
Male 66 (44.9) 26 (38.2)
Female 81 (55.1) 42 (61.8)
Indigeneity- Aboriginal/Torres
Strait Islander, n (%)
–
Yes 0 (0) 0 (0)
No 147 (100.0) 68 (100.0)
Country of birth, n (%) .51
Australia 114 (81.4) 52 (85.2)
Other 26 (18.6) 9 (14.8)
Lives with patient, n (%) .41
Yes 121 (82.3) 59 (86.8)
No 26 (17.7) 9 (13.2)
Relationship to patient, n (%) .93
Spouse/partner 116 (78.9) 54 (79.4)
Other
(i.e. parent, adult child, friend)
31 (21.1) 14 (20.6)
Household size, mean (SD)
Number of people ≥18 years 2.2 (0.8) 2.3 (0.7) .35
Number of people <18 years 0.4 (0.7) 0.6 (1.1) .10
Total household size 2.5 (1.0) 2.9 (1.3) .04
Education status, n (%) .06
Primary/secondary school 70 (47.6) 24 (35.8)
Certificate/Diploma 29 (19.7) 23 (34.3)
University Degree 48 (32.7) 20 (29.9)
a One caregiver in the intervention condition had missing data for the
ZBI and, therefore, wasn’t included in the analysis
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needs previously reported in the literature [4].
Researchers have stressed the importance of targeting
caregivers’ needs to minimise long-term health problems
[5, 8, 9]. Therefore, our program, which addressed
caregivers’ unique needs at the early stages of the cancer
trajectory, may be a good approach in preventing long-
term negative health outcomes in caregivers. This
hypothesis warrants further investigation.
We hypothesised that improved caregiver outcomes
would impact positively on patient health and well-
being. However, the outcall program had no significant
effect on patient outcomes and our subgroup of bur-
dened caregivers (ZBI >24) was possibly underpowered
to detect significant improvements in patient outcomes.
Targeting dyad interventions to specific subgroups
(e.g. significantly burdened caregivers) may be more
effective in improving patient wellbeing, however
more research is needed to support this argument.
The outcall program was reported as beneficial by trial
participants. The majority of caregivers stated that the
outcalls helped them to reduce their worries and think
more positively about their situation. These findings sug-
gest that the program was acceptable to caregivers and
may represent a feasible approach to provide informa-
tion and support to a targeted population.
Limitations of this study included a modest recruit-
ment rate of 29%, which reflects the difficulty of enrol-
ling cancer dyads into randomised trials consistently
reported in the literature [28–31]. It is possible that eli-
gible dyads who experienced significant burden declined
participation due to the perceived burden of taking part
in research, even though the intervention may have been
of benefit to them. The overall attrition rate (30%) in
this study at month 1 was higher than the estimated
attrition rate of 20%. Further, we cannot rule out that
caregivers in the attention control group actively sought
support elsewhere as their unmet needs also declined
from baseline to month 1. Despite these limitations, the
findings suggest that access to support services for
caregivers, who are at risk for depression, can ameliorate
the demands of caregiving and potentially improve qual-
ity of life outcomes; telephone information support ser-
vices are a feasible approach to providing such access
and warrant further investigation in this high risk group.
Conclusion
While the 4-month telephone outcall program did not re-
duce caregiver burden, it was effective in reducing care-
givers’ reported unmet supportive care needs. One third of
caregivers were found to be at risk of depression and this
was particularity the case in younger caregivers and those
residing in larger households. Findings suggest that the
provision of cancer information and support via a tele-
phone service may represent a feasible approach to address
caregivers’ unique needs at the early stages of the cancer
trajectory. However, the role of a telephone service to help
prevent medium- and long-term negative health outcomes
in this population group warrants further research.
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